BDBM50316101 3-Methyl-2-[4'-(methylsulfonyl)biphenyl-3-yl]-5-(trifluoromethyl)quinoxaline::CHEMBL1093259

SMILES Cc1nc2c(cccc2nc1-c1cccc(c1)-c1ccc(cc1)S(C)(=O)=O)C(F)(F)F

InChI Key InChIKey=ZOAHFZQNTOTYOA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50316101   

TargetOxysterols receptor LXR-alpha(Homo sapiens (Human))
Wyeth Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50316101(3-Methyl-2-[4'-(methylsulfonyl)biphenyl-3-yl]-5-(t...)
Affinity DataIC50: >1.00E+3nMAssay Description:Displacement of [3H]T0901317 from human LXRalpha ligand binding domainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Wyeth Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50316101(3-Methyl-2-[4'-(methylsulfonyl)biphenyl-3-yl]-5-(t...)
Affinity DataIC50: >1.00E+3nMAssay Description:Displacement of [3H]T0901317 from human LXRbeta ligand binding domainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed